Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

BUY
$0.41 - $0.91 $179,202 - $397,741
437,079 Added 109.05%
837,899 $343,000
Q1 2022

May 13, 2022

BUY
$0.79 - $1.59 $133,681 - $269,055
169,217 Added 73.06%
400,820 $333,000
Q4 2021

Feb 11, 2022

BUY
$1.36 - $2.94 $101,805 - $220,079
74,857 Added 47.76%
231,603 $315,000
Q3 2021

Nov 04, 2021

BUY
$2.97 - $4.84 $304,986 - $497,014
102,689 Added 189.96%
156,746 $472,000
Q2 2021

Aug 11, 2021

SELL
$3.71 - $5.13 $59,508 - $82,285
-16,040 Reduced 22.88%
54,057 $250,000
Q1 2021

May 13, 2021

SELL
$4.08 - $14.75 $246,999 - $892,950
-60,539 Reduced 46.34%
70,097 $301,000
Q4 2020

Feb 16, 2021

SELL
$11.06 - $14.01 $158,169 - $200,357
-14,301 Reduced 9.87%
130,636 $1.45 Million
Q3 2020

Nov 12, 2020

SELL
$10.26 - $14.55 $569,830 - $808,092
-55,539 Reduced 27.7%
144,937 $1.75 Million
Q2 2020

Aug 13, 2020

BUY
$7.11 - $13.76 $1.12 Million - $2.16 Million
156,946 Added 360.55%
200,476 $2.76 Million
Q1 2020

May 14, 2020

BUY
$5.71 - $15.85 $105,566 - $293,034
18,488 Added 73.83%
43,530 $336,000
Q4 2019

Feb 14, 2020

SELL
$9.6 - $17.75 $442,627 - $818,399
-46,107 Reduced 64.8%
25,042 $382,000
Q3 2019

Nov 14, 2019

BUY
$12.16 - $21.0 $429,418 - $741,594
35,314 Added 98.55%
71,149 $864,000
Q2 2019

Aug 14, 2019

BUY
$9.44 - $19.8 $69,572 - $145,926
7,370 Added 25.89%
35,835 $707,000
Q1 2019

May 15, 2019

SELL
$11.11 - $13.49 $6,821 - $8,282
-614 Reduced 2.11%
28,465 $347,000
Q4 2018

Feb 14, 2019

SELL
$10.24 - $15.49 $1.31 Million - $1.99 Million
-128,222 Reduced 81.51%
29,079 $368,000
Q3 2018

Dec 21, 2021

BUY
$15.53 - $19.97 $1.07 Million - $1.38 Million
68,964 Added 78.07%
157,301 $2.44 Million
Q3 2018

Nov 14, 2018

SELL
$15.53 - $19.97 $176,840 - $227,398
-11,387 Reduced 11.42%
88,337 $1.37 Million
Q2 2018

Apr 21, 2020

BUY
$15.88 - $19.5 $369,781 - $454,077
23,286 Added 30.46%
99,724 $1.86 Million
Q2 2018

Aug 14, 2018

BUY
$15.88 - $19.5 $149,081 - $183,066
9,388 Added 14.0%
76,438 $1.43 Million
Q1 2018

Oct 18, 2019

BUY
$13.53 - $17.47 $568,720 - $734,333
42,034 Added 168.03%
67,050 $1.14 Million
Q1 2018

May 15, 2018

BUY
$13.53 - $17.47 $88,012 - $113,642
6,505 Added 35.14%
25,016 $424,000
Q4 2017

Feb 14, 2018

BUY
$14.41 - $19.15 $175,023 - $232,595
12,146 Added 190.82%
18,511 $293,000
Q3 2017

Nov 14, 2017

BUY
$13.5 - $19.51 $85,927 - $124,181
6,365
6,365 $110,000

Others Institutions Holding ATNX

About Athenex, Inc.


  • Ticker ATNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 156,790,000
  • Market Cap $1.57M
  • Description
  • Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...
More about ATNX
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.